The Revlar Labs approach to infectious disease diagnostics stands to disrupt the commercial and laboratory markets. Diagnostic efforts include Covid-targeted assays using patented biosensors in vitro, alongside on-site and Point of Care diagnostic solutions.

Bypass the challenges associated with typical PCR and rapid antigen tests for COVID. Revlar Labs has designed a better diagnostic solution offering speed, simplicity and sensitivity with the ability for labs to scale accurate, rapid-results tests.

CLIA LAB solutions including
Hinged Peptid molecular nanoswitches
Covid-targeted assay development
High-Throughput Lab (HTL) kits

ON-SITE COVID SOLUTIONS for 
Point of Care providers
Venues
Employers 
School Campuses

CONTACT
Tony@Revlarlabs.com

Biotechnology

Health Care

Revlar Diagnostics

Org chart

Similar companies